ARTICLE | Clinical News
DMP 115 perfluorocarbon: Partner Yamanouchi Pharmaceutical Co. Ltd. began clinical testing
June 29, 1998 7:00 AM UTC
ImaRx Pharmaceutical Corp., Tucson, Ariz. Product: DMP 115 perfluorocarbon ultrasound contrast agent Indication: Cardiologic and radiologic imaging Status: Partner Yamanouchi Pharmaceutical Co. Ltd....